KLab is manufacturing these specialty APIs.
KLab has a dedicated oncology facility for manufacturing various APIs. KLab also has a separate sterile powder manufacturing facility. The API dossier’s available are equivalent to CTD (Europe), DMF (US) standards subject to site approvals. KLab has got WHO GMP/ cGMP / ISO 14001 / ISO 9001 and GLP certifications.
Chiral Synthesis has become important in research and Industry due to the need for increased pathways for identifying active enantiomers in the rascemic mixture. This leads to strong and fast growing range of new chiral building blocks, chiral catalysts and the increased use of chiral biotransformation in organic synthesis.
KLab is one of the pioneers in India in KLAB is a pioneer in the Indian Oncology formulations market. It has one of the widest range of Oncology formulations, which are manufactured at KLAB owned WHO-GMP approved facility at Thane, Mumbai.
KLAB manufactures tablets, capsules, powder and liquid injectables.
KLAB’s oncology products are now registered in more than 30 countries in Africa, Latin America, CIS and South East Asia. In India KLAB has a dedicated Oncology task force which covers Oncologists and Oncology Institutions across the length and breadth of India. Further, KLAB supplies finished ONCO formulations to a large number of Indian Companies.
Camylofin DiHCL and Its combinations – Anafortan group(Camylofin DiHCL+Paracetamol tablets, Camylofin Amps / vials, Camylofin+Diclofinac tablets / amps) Licensed to Abbot.
Antispasmodic Methocarbamol Group – Methocarbamol+Diclofenac + Paracetamol tablets, Methocarbamol+Diclofenac ampoules, Methocarbamol+Ibuprofen tablets, Methocarbamol tablets/ampoules. Muscle Relaxants Cefiximie OD and Cefixime+Cloxacilin/Di cloxacilin+lab Combination tablets.
Cefpodoxime Proxitile + Di cloxacilin + lab Combination tablets Antibiotic Prenoxdiazine HCl tablets Antitussive